A levodopa decarboxylase inhibitor, Bensarazide Hydrochloride’s active substance prevents the breakdown of L-dopamine. It is used to treat of Parkinson’s and restless leg syndrome.

Formula: C₁₀H₁₅N₃O₅ • HCl

Molecular weight: 293.70 g/mol

Molecular size: Small

Controlled Substance: No

Precursor: No

Indications: Anti-Parkinson’s

Status: Commercial